コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 erfluorescent plaque in the late frame (late plaque).
2 th carotid artery intima-media thickness and plaque.
3 sms than inflammation in the atherosclerotic plaque.
4 and Gal-3 were not associated with increased plaque.
5 old promise for identification of vulnerable plaque.
6 re on antiretroviral medication, and 50% had plaque.
7 e can identify culprit and high-risk carotid plaque.
8 higher (95% CI, 2.2-17.8) burden of carotid plaque.
9 owed no evidence of coronary atherosclerotic plaque.
10 patients with stable versus unstable carotid plaque.
11 ted microglia that surround the beta-amyloid plaques.
12 sion molecule 1 (VCAM-1), in atherosclerotic plaques.
13 he calcium deposits in human atherosclerotic plaques.
14 in the perivascular area of atherosclerotic plaques.
15 mediated by an accumulation of amyloid beta plaques.
16 higher prevalence of CAC and atherosclerotic plaques.
17 mixed plaques and more often only calcified plaques.
18 acrophage burden in advanced atherosclerotic plaques.
19 nificantly different between NRS and non-NRS plaques.
20 pment and the progression of atherosclerotic plaques.
21 reduce macrophage burden in atherosclerotic plaques.
22 d 8.7% for white women; P < .01) of multiple plaques.
23 lets at the site of ruptured atherosclerotic plaques.
24 E binding in macrophages and excised carotid plaques.
25 analysis improves the identification of NRS plaques.
26 anscript expression in human atherosclerotic plaques.
27 kers in both mouse and human atherosclerotic plaques.
28 wellings at Alzheimer's disease (AD) amyloid plaques.
29 on the structural or molecular properties of plaques.
32 athletes demonstrated predominantly calcific plaques (72.7%), whereas sedentary males showed predomin
33 ; 95% confidence interval [CI], 1.6-6.6) and plaque (77%; ORadjusted=3.3; 95% CI, 1.6-7.1) compared w
34 tive detection and staining of toxic amyloid plaques, a potential biomarker present in the Alzheimer'
38 ed to resemble the substrate of human eroded plaques, acute flow perturbation promoted downstream end
39 ial clustering around plaques, and decreased plaque-adjacent neuronal dystrophy in TREM2-deficient mi
40 depending on Braak stage, when adjusting for plaques, age of death, sex, education, and APOE genotype
41 he titanium dioxide (TiO2) layer, and scanty plaque aggregates, whereas the Er:YAG laser (38.2 J/cm(2
43 h their contributory role to atherosclerotic plaque and abdominal aortic aneurysm stability are poorl
44 rediabetes had an increased risk for carotid plaque and adverse functional cardiac parameters, includ
45 ri-implantitis are evaluated in terms of: 1) plaque and biocorroded titanium oxide coating removal; 2
46 nderlying molecular mechanisms that regulate plaque and CAA deposition in the vast majority of sporad
49 (38.2 J/cm(2)) completely stripped away the plaque and TiO2 layer, leaving a micropitted surface.
51 pressed in symptomatic human atherosclerotic plaques and abdominal aortic aneurysms and correlated wi
52 n macrophage-rich regions of atherosclerotic plaques and correlated with the intensity of CXCR4 expre
53 as examined in human carotid atherosclerotic plaques and in western diet-fed atherosclerosis-prone Ld
56 C, V181M, R183C and L239I) form gap junction plaques and produce levels of junctional coupling simila
57 rystals (CC) are abundant in atherosclerotic plaques and promote inflammatory responses via the compl
59 ggregated beta-amyloid and tau proteins into plaques and tangles is a central feature of Alzheimer di
62 explored by 3DVUS to determine the number of plaques and territories affected, and to quantify global
64 its containing by the Abeta peptide (amyloid plaques) and the tau protein (neurofibrillary tangles) i
65 linical research for imaging coronary artery plaque, and ongoing clinical studies are testing whether
66 phagy, restored microglial clustering around plaques, and decreased plaque-adjacent neuronal dystroph
68 ATEMENT Tau tangles and beta-amyloid (Abeta) plaques are key lesions in Alzheimer's disease (AD) but
69 ial activation, also takes place outside the plaque areas, that is, in areas of normal-appearing whit
70 ssolved titanium were detected in submucosal plaque around implants with peri-implantitis compared wi
72 he biodistribution, nanomedicines' uptake by plaque-associated macrophages/monocytes, and their effic
73 ease in Abeta plaque size and a reduction in plaque-associated neuritic dystrophy with no change in o
75 irin had no significant effect on individual plaque bacterial counts in unadjusted models or those ad
76 derived pathological tau (AD-tau) into Abeta plaque-bearing mouse models that do not overexpress tau,
77 h heavy infection of Streptococcus mutans in plaque-biofilms from children affected with early-childh
78 n in patients treated with repeat episcleral plaque brachytherapy (EPBT) for locally recurrent poster
80 with psoriasis had increased total coronary plaque burden (1.22+/-0.31 versus 1.04+/-0.22, P=0.001),
81 ssociated with improvement in total coronary plaque burden (beta=0.45, 0.23-0.67; P<0.001) and NCB (b
83 nary plaque burden and noncalcified coronary plaque burden (NCB) and high-risk plaque (HRP) prevalenc
84 eatures (remodeling index [r=0.53, P=0.003], plaque burden [r=0.51, P=0.004]), and predicted cardiova
86 As such, we sought to compare total coronary plaque burden and noncalcified coronary plaque burden (N
88 territories affected, and to quantify global plaque burden defined as the sum of all plaque volumes.
89 eficiency in endothelial autophagy increased plaque burden only in the atheroresistant areas exposed
91 ts of bexarotene were accompanied by reduced plaque burden, decreased astrogliosis, and suppression o
93 alcification and low attenuation) of carotid plaque by computerized tomography among PLWHIV without k
97 ve specimens of Neanderthal calcified dental plaque (calculus) and the characterization of regional d
98 The incidence of carotid artery stenosis and plaques, cardiac embolic source, TIA/stroke and myocardi
99 presence of parenchymal amyloid-beta (Abeta) plaques, cerebral amyloid angiopathy (CAA) and neurofibr
100 sive method for direct assessment of CAD and plaque characterization with high diagnostic accuracy co
101 h concurrent Abeta suppression could enhance plaque clearance and could improve pathologic outcomes i
103 ineffective plaque encapsulation and reduced plaque compaction, which is associated with worsened axo
104 ole of vascular CXCR4 in atherosclerosis and plaque composition by inducing an endothelial cell (BmxC
105 nous estradiol and testosterone with carotid plaque composition in elderly men and postmenopausal wom
106 Aggregates of tau and beta amyloid (Abeta) plaques constitute the histopathological hallmarks of Al
107 d carotid, iliofemoral, and abdominal aortic plaques; coronary artery calcification; serum biomarkers
109 t age-related increases in Abeta production, plaque deposition, as well as contextual fear and spatia
110 cosanoids are thought to contribute to Abeta plaque deposition, these 1,5-diarylimidazoles provide to
111 nd tau fragmentation and facilitates amyloid plaque deposits and neurofibrillary tangle (NFT) formati
112 more effective reductions of brain Abeta and plaque deposits, gliosis, and behavioral memory deficits
114 and determine the impact on atherosclerotic plaque development in mice with and without CD4+ T cells
115 eria and individual species counts in dental plaque did not differ significantly between baseline and
116 surements, and explored the mechanism of any plaque DOTATATE activity with immunohistochemistry in re
117 d amyloid deposits, resulting in ineffective plaque encapsulation and reduced plaque compaction, whic
118 we can reverse the autophagy dysfunction of plaques, enhance aggrephagy of p62-enriched protein aggr
119 ompanied by an acute decrease in the carotid plaque expression of micro-RNAs (miRs)-221 and miR-222.
120 )F-Fluoride uptake correlated with high-risk plaque features (remodeling index [r=0.53, P=0.003], pla
121 rease in sCD14 was associated with increased plaque formation (risk ratio [RR] 1.24, 95% confidence i
122 K-null phenotype characterized by very small plaque formation and drastic reduction in infectious vir
124 ic flux under high SS limits atherosclerotic plaque formation by preventing endothelial apoptosis, se
125 ction, pseudorevertant alleles that restored plaque formation for lysis-defective mutants of Rz and R
128 ces colonization and contributions to dental plaque formation, as well as their potential roles in th
129 nockout mice show diminished atherosclerotic plaque formation, characterized by reduced proinflammato
134 4 followed by intramuscular injection of 108 plaque forming units of MVA-CMDR at weeks 12 and 24.
135 e doses of the rVSV-ZEBOV vaccine (3 million plaque-forming units [PFU], 20 million PFU, or 100 milli
136 1 of 3 lots of rVSVDeltaG- ZEBOV-GP (2 x 107 plaque-forming units [pfu], n = 797; combined-lots group
138 egan in week 1 (first dose, </= 4 mL x 10(6) plaque-forming units/mL; after 3 weeks, </= 4 mL x 10(8)
139 st M2FA demonstrated that M2FA is present in plaque found on the aortic valve of ApoE (-/-) mice.
140 anium surfaces contaminated with subgingival plaque from patients with peri-implantitis are evaluated
141 using gentle sonication to sample intact Fe plaque from the root system and concentrate it for subse
143 gamma-tubulin receptor Spc110 to the central plaque from within the nucleus is important for NE inser
144 cause mortality risk were raised with dental plaque, gingival inflammation, >10 missing teeth and fun
146 d coronary plaque burden (NCB) and high-risk plaque (HRP) prevalence between patients with psoriasis
149 relates with their associations with amyloid plaques in Alzheimer's brains: RTN3, but not RTN1, is ab
150 the predominantly calcific morphology of the plaques in athletes indicates potentially different path
151 Remarkably, IAPP colocalized with amyloid plaques in brain parenchymal deposits, suggesting that t
152 CYnLIP efficaciously treated psoriatic-like plaques in C57BL/6 mice (PASI score of 1) compared to im
153 so expressed in EC overlying atherosclerotic plaques in coronary arteries from patients with ischemic
154 the number of viral particles that can form plaques in culture is much lower in human neurons than o
156 in necrotic and symptomatic atherosclerotic plaques in humans as well as advanced atherosclerotic le
158 's disease through their presence in amyloid plaques in the nervous systems of affected individuals.
159 Presence and characteristics (high-risk plaque, including spotty calcification and low attenuati
160 egression, the presence of nonobstructive LM plaque increased the risk for the composite outcome in w
163 luded modified sulcus bleeding index (mSBI), plaque index (PI), probing depth (PD), and clinical atta
164 compare peri-implant soft tissue parameters (plaque index [PI], bleeding on probing [BOP], and probin
170 preclinical technology to assess and monitor plaque instability and thereby test potential plaque-sta
171 l Th1 inflammatory response, with subsequent plaque instability that eventually favors atherothrombos
173 ndividual isolates of PIV5-RSV-G (HN-L), but plaque isolates of PIV5-RSV-F (HN-L) had no mutations.
175 onectin in the neointima and atherosclerotic plaque lesions, and the adiponectin-T-cadherin associati
176 stase, and sialidase) in GCF and subgingival plaque levels of Porphyromonas gingivalis, Tannerella fo
184 en with S-ECC have a significantly different plaque microbiome than their caries-free counterparts, w
185 in individual species levels in subgingival plaque microbiota were not detectable; however, a small
186 d was effective at concentrating As-bound Fe plaque minerals in a uniform coating onto membranes that
188 er she noticed a periareolar ulcerating skin plaque, more noticeable nipple retraction, and new onset
189 stitutions show in vitro growth kinetics and plaque morphologies similar to those of the wild-type (W
190 an increase in CEC and beneficial changes in plaque morphology including increase in fibrous cap thic
191 gard to their growth kinetics, antigenicity, plaque morphology, genetic stability, and temperature, i
192 imaging-based definitions of the "vulnerable plaque," necessitating an improved approach for predicti
194 otid plaques, MerTK cleavage correlated with plaque necrosis and the presence of ischemic symptoms.
196 that contributes to defective efferocytosis, plaque necrosis, and impaired resolution during the prog
198 's disease (AD) include amyloid-beta (Abeta) plaques, neurofibrillary tangles, and reactive gliosis.
199 categorical measures for certain non-amyloid-plaque, non-neurofibrillary-tangle neuropathologies.
200 tes in dystrophic neurites surrounding Abeta plaques (NP tau), AD-like neurofibrillary tangles (NFTs)
201 ue presence), negative binominal regression (plaque number), and linear regression (plaque size), and
203 elf-described red, itchy skin within a large plaque of FDH on her left posterior thigh and calf.
204 :background ratio were higher in the carotid plaque of symptomatic patients (P=0.021 and P=0.05, resp
206 reduced necrosis and macrophage apoptosis in plaques of these mice was a manifestation of the selecti
207 zed at the site of high-risk atherosclerotic plaques, of which early detection and therapeutic stabil
212 Y) either form no morphological gap junction plaques or, if they do, produce little or no detectable
213 cation of the culprit lesion; or whether the plaque (or patient) is at high risk of future adverse ev
214 ion was observed for number of teeth, dental plaque, or detectable oral mucosal lesions and PD risk,
216 was revealed by the worsening of the amyloid plaque pathology arising from JIP3 haploinsufficiency in
222 tions were determined by Poisson regression (plaque presence), negative binominal regression (plaque
224 8 years or older, had a diagnosis of chronic plaque psoriasis for at least 6 months before baseline,
225 atients (aged >/=4 to <18 years) with severe plaque psoriasis who had not responded to topical therap
234 stic strategy in developing countries, where plaque reduction neutralization testing is impractical.
237 ry, and controlled OAS treatment of calcific plaques resulted in greater drug permeability and improv
239 rrent evidence suggests that a sole focus on plaque rupture vastly oversimplifies this complex collec
245 An in vitro three-species biofilm or human plaque samples were applied for bacterial adhesion to ea
248 ine density was not associated with neuritic plaque score but did display negative correlation with B
249 sure versus number of teeth, bleeding score, plaque score, and periodontal severity with linear and o
250 ncluded age at death, sex, cerebral neuritic plaque scores, cerebral alpha-synuclein scores, presence
251 n or inflammation in response to accumulated plaque select for a cariogenic or periopathogenic microb
253 yloid deposition led to an increase in Abeta plaque size and a reduction in plaque-associated neuriti
254 (-/-) mouse model to compare atherosclerotic plaque size and composition after inorganic arsenic, met
255 ngage from ZO-1 correlated with increased GJ plaque size and increased connexin protein half-life, wh
256 he atheroresistant areas exposed to high SS; plaque size was unchanged in atheroprone areas, in which
257 mmune responses, and reduced atherosclerotic plaque size without altering the plasma lipid profiles i
259 GAPDH levels were reduced in atherosclerotic plaque SMCs, and this effect correlated with oxidative s
260 By identifying the residues that establish plaque stability, these studies lay the groundwork for e
264 ts noted significant healing of erosions and plaques starting from the peripheral aspect within 1 to
266 bbits subject to pharmacological triggering, plaques that thrombosed exhibited significantly higher C
268 wn experimentally (in the absence of amyloid plaques) to impair hippocampal synaptic plasticity, decr
271 The predominant strategy to characterize Fe plaque using dithionite-citrate-bicarbonate (DCB) extrac
272 arterectomized human carotid atherosclerotic plaques using three-dimensional (3D) electron microscopy
275 pt uptake was related to noncalcified aortic plaque volume (r = 0.87; P = .003) on computed tomograph
276 ncrease [95% confidence interval] in rank of plaque volume for each 10-year increase in cumulative du
277 gnificantly greater increase in noncalcified plaque volume from baseline to 12 months (from median va
278 ary outcome was noncalcified coronary artery plaque volume, as determined by coronary computed tomogr
282 ization are acknowledged to be 2 features of plaque vulnerability, although their temporal expression
284 HODS AND A high-density fixed multielectrode plaque was placed on the epicardial surface of the left
285 50 patients with periodontitis, subgingival plaque was sampled from the deepest pocket of each quadr
287 ILPDA is highly expressed in atherosclerotic plaques, we examined its regulation and function in muri
289 Braak NFT stage and the presence of neuritic plaques were not significantly associated with differenc
290 KB1 expression was markedly reduced in human plaques when compared with nonatherosclerotic vessels.
291 aneously from instability of atherosclerotic plaque, whereas type 2 MIs occur in the setting of a mis
292 o assess differences between NRS and non-NRS plaques, whereas we calculated receiver-operating charac
293 more quickly than the paxillin-rich adhesion plaques, which in turn move more quickly than the local
295 uced progression to advanced atherosclerotic plaques with diminished smooth muscle and collagen conte
298 p, however, had a more benign composition of plaques, with fewer mixed plaques and more often only ca
299 h worldwide and involves the accumulation of plaques within the artery wall that can occlude blood fl
300 rden in the presence of moderate or frequent plaques would add to the ability to predict clinical rat
301 sed for identifying fibrous cap thickness of plaques, yet cannot provide adequate depth penetration t
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。